Category Archives: Medtronic Infuse

Featured Stories

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

DeflateGate’s Effects Impact Legal Gambling and the Economy

DeflateGate’s Effects Impact Legal Gambling and the Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Medtronic Settles Charges Over Kickbacks To Doctors

Medical device giant, Medtronic Inc., is settling charges over kickbacks to doctors. The firms just agreed to pay $23.5 million to settle claims it paid physicians kickbacks in exchange for their use of its pacemakers and defibrillators, according to a U.S. Justice Department announcement yesterday. The company was accused of seeking ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Medtronic Seeks Reconsideration of Infuse Ruling


Device maker, Medtronic, just asked a federal judge to reconsider a ruling in a lawsuit involving its bone growth protein product, Infuse. Medtronic asked Judge G. Murray Snow, U.S. District Court for Arizona, to dismiss the lawsuit on the grounds … Continue reading

Posted in Defective Medical Devices, Defective Products, Medtronic Infuse |

Medtronic’s InFuse Sales Soft for Second Quarter Over Safety Issues


Revenues for the bone graft product, InFuse, were down for the second quarter, due to ongoing safety issues. Medtronic’s InFuse, has long been steeped in controversy, including a Senate probe, a warning issued by a federal regulator, accusations that Medtronic … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Cincinnati Spine Surgeon Facing Fraud Charges Over InFuse


A Cincinnati spine surgeon has been charged with millions of dollars in fraudulent billing for unnecessary operations using Medtronic’s bone-growth product Infuse. Dr. Abubakar Atiq Durrani, who has a private practice with offices in Evendale and Florence, Kentucky called Center … Continue reading

Posted in Medtronic Infuse |

Industry Promises Increased Transparency, Medtronic InFuse Debacle Cited


Some of the world’s largest drug makers have promised to release detailed information about their pharmaceutical products, such as Medtronic’s InFuse, to external researchers. While many are happy with the move, others point out that this might be a way … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic’s Motion to Dismiss InFuse Lawsuit Denied


An Illinois state court judge just denied device maker, Medtronic Inc.’s, bid to dismiss a lawsuit brought over its InFuse bone graft product. The lawsuit included allegations that InFuse caused a patient to undergo additional surgery that led to permanent … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Pending Sunshine Act to Focus on Allegedly Fraudulent Financial Ties Between Physicians and Industry


On August 1, the Physician Payment Sunshine Act provision of the Affordable Care Act will go into effect. The Act is meant to highlight allegedly bogus relationships between physicians and pharmaceutical firms and medical device manufacturers. As we’ve long stressed, … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Increased Transparency in Medicine Coming


When approved by the U.S Food and Drug Administration in 2002, Medtronic’s bone graft product, InFuse, was seen as a medical breakthrough. InFuse eliminated the need to remove patient bone from the hip in spinal fusions and could, instead, use … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Injured InFuse Users Working Toward Their Day in Court


Hundreds of people allegedly injured following procedures involving Medtronic’s InFuse are utilizing a different legal approach. The arguments planned include that the U.S. Food and Drug Administration (FDA) issued a warning in 2008 to physicians concerning “life-threatening complications” from unapproved … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Do Consumers Know the Risks of Medtronic InFuse? Are Consumers Aware of Safer Options?


Medtronic’s bone graft product, InFuse, is a synthetic, or genetically engineered, recombinant human Bone Morphogenetic Protein (rhBMP-2) that was approved by the U.S. Food & Drug Administration (FDA) in 2002 for specific uses. Meant to stimulate spine growth in patients … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic Shareholders File Lawsuit Amid InFuse® Scandal


  Device maker, Medtronic, is the focus of another shareholder lawsuit over its InFuse® bone growth product. Shareholders filed the lawsuit against Medtronic and some of its shareholders accusing them of intentionally minimizing potential dangers associated with InFuse® so that … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.